Abiomed Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
ABT | Abbott Laboratories | Outperform |
9
|
$103.95 | $118.92 | 20.25% | 7 | $180.83B |
BSX | Boston Scientific | Buy |
11
|
$75.63 | $70.14 | 8.42% | 6 | $111.19B |
MDT | Medtronic | Outperform |
11
|
$82.29 | $92.47 | 16.66% | 9 | $107.91B |
EW | Edwards Lifesciences Corp | Outperform |
11
|
$87.98 | $91.18 | 13.66% | 5 | $53.02B |
TFX | Teleflex Inc | Hold |
13
|
$206.35 | $263.46 | 16.79% | 2 | $9.64B |
HAE | Haemonetics | Outperform |
16
|
$88.34 | $70.17 | 33.01% | 1 | $4.87B |
MMSI | Merit Medical Systems | Outperform |
14
|
$81.92 | $89.25 | 8.03% | 0 | $4.65B |
ITGR | Integer Holdings | Outperform |
16
|
$122.63 | $95.00 | 8.05% | 0 | $3.83B |
ICUI | ICU Medical | Outperform |
16
|
$101.68 | $153.50 | 34.24% | 3 | $2.48B |
CNMD | CONMED | Outperform |
16
|
$74.07 | $123.38 | 16.78% | 1 | $2.09B |
IART | Integra LifeSciences Holdings | Hold |
16
|
$28.31 | $46.60 | -4.63% | 4 | $1.82B |
LMAT | LeMaitre Vascular | Outperform |
18
|
$79.75 | $59.86 | -3.45% | 0 | $1.45B |
NVRO | Nevro | Hold |
6
|
$9.39 | $21.34 | 38.45% | 1 | $422.94M |
STXS | Stereotaxis | Buy |
7
|
$1.98 | $4.25 | 127.27% | 1 | $179.03M |